Annual SG&A:
$0.00-$10.24M(-100.00%)Summary
- As of today, TRVI annual SG&A is $0.00, with the most recent change of -$10.24 million (-100.00%) on December 31, 2024.
- During the last 3 years, TRVI annual SG&A has fallen by -$9.49 million (-100.00%).
- TRVI annual SG&A is now -100.00% below its all-time high of $10.24 million, reached on December 31, 2023.
Performance
TRVI SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$3.66M(-100.00%)Summary
- As of today, TRVI quarterly SG&A is $0.00, with the most recent change of -$3.66 million (-100.00%) on June 30, 2025.
- Over the past year, TRVI quarterly SG&A has dropped by -$3.27 million (-100.00%).
- TRVI quarterly SG&A is now -100.00% below its all-time high of $3.66 million, reached on March 31, 2025.
Performance
TRVI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.17B-$47.30M(-4.21%)Summary
- As of today, TRVI TTM SG&A is -$1.17 billion, with the most recent change of -$47.30 million (-4.21%) on June 30, 2025.
- Over the past year, TRVI TTM SG&A has dropped by -$1.18 billion (-10265.52%).
- TRVI TTM SG&A is now -1285.43% below its all-time high of -$84.43 million.
Performance
TRVI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
TRVI Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -100.0% | -100.0% | -10000.0% |
3Y3 Years | -100.0% | -100.0% | -10000.0% |
5Y5 Years | -100.0% | -100.0% | -10000.0% |
TRVI Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -100.0% | at low | -100.0% | at low | -51.9% | at low |
5Y | 5-Year | -100.0% | at low | -100.0% | at low | -131.9% | at low |
All-Time | All-Time | -100.0% | at low | -100.0% | at low | -1285.4% | at low |
TRVI Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $0.00(-100.0%) | $6.52M(-33.4%) |
Mar 2025 | - | $3.66M(>+9900.0%) | $9.79M(+6.0%) |
Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $9.23M(-20.7%) |
Sep 2024 | - | $2.86M(-12.4%) | $11.65M(+1.2%) |
Jun 2024 | - | $3.27M(+5.4%) | $11.51M(+6.8%) |
Mar 2024 | - | $3.10M(+28.4%) | $10.78M(+5.3%) |
Dec 2023 | $10.24M(+1.7%) | $2.42M(-11.3%) | $10.24M(+0.7%) |
Sep 2023 | - | $2.72M(+7.2%) | $10.16M(+0.9%) |
Jun 2023 | - | $2.54M(-0.9%) | $10.08M(-1.7%) |
Mar 2023 | - | $2.56M(+9.5%) | $10.26M(+1.8%) |
Dec 2022 | $10.07M(+6.1%) | $2.34M(-11.2%) | $10.07M(+2.5%) |
Sep 2022 | - | $2.64M(-3.0%) | $9.83M(+4.3%) |
Jun 2022 | - | $2.72M(+14.2%) | $9.42M(+0.5%) |
Mar 2022 | - | $2.38M(+13.7%) | $9.37M(-1.3%) |
Dec 2021 | $9.49M | $2.09M(-6.1%) | $9.49M(-5.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $2.23M(-16.5%) | $10.03M(-1.8%) |
Jun 2021 | - | $2.67M(+6.8%) | $10.22M(+1.8%) |
Mar 2021 | - | $2.50M(-5.1%) | $10.04M(-1.2%) |
Dec 2020 | $10.16M(+39.1%) | $2.63M(+9.0%) | $10.16M(+7.3%) |
Sep 2020 | - | $2.42M(-3.0%) | $9.47M(+4.6%) |
Jun 2020 | - | $2.49M(-4.9%) | $9.05M(+7.1%) |
Mar 2020 | - | $2.62M(+34.8%) | $8.45M(+15.7%) |
Dec 2019 | $7.31M(+68.5%) | $1.94M(-2.9%) | $7.31M(+7.9%) |
Sep 2019 | - | $2.00M(+5.9%) | $6.77M(+41.9%) |
Jun 2019 | - | $1.89M(+28.2%) | $4.77M(+24.8%) |
Mar 2019 | - | $1.47M(+4.8%) | $3.82M(+62.8%) |
Dec 2018 | $4.34M(>+9900.0%) | $1.41M(+49.4%) | $2.35M(+50.0%) |
Jun 2018 | - | $941.00K(+50.8%) | $1.56M(+150.8%) |
Dec 2017 | $0.00(-100.0%) | - | - |
Dec 2017 | - | $624.00K | $624.00K |
Dec 2016 | $1.71M | - | - |
FAQ
- What is Trevi Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. annual SG&A year-on-year change?
- What is Trevi Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Trevi Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. TTM SG&A year-on-year change?
What is Trevi Therapeutics, Inc. annual SG&A?
The current annual SG&A of TRVI is $0.00
What is the all-time high annual SG&A for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high annual SG&A is $10.24M
What is Trevi Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, TRVI annual SG&A has changed by -$10.24M (-100.00%)
What is Trevi Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of TRVI is $0.00
What is the all-time high quarterly SG&A for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high quarterly SG&A is $3.66M
What is Trevi Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, TRVI quarterly SG&A has changed by -$3.27M (-100.00%)
What is Trevi Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of TRVI is -$1.17B
What is the all-time high TTM SG&A for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high TTM SG&A is -$84.43M
What is Trevi Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, TRVI TTM SG&A has changed by -$1.18B (-10265.52%)